Navigation Links
Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
Date:6/22/2009

assumptions and uncertainties. The inclusion of forward-looking statements should not be regarded as a representation by Amicus that any of its plans will be achieved. Any or all of the forward-looking statements in this press release may turn out to be wrong. They can be affected by inaccurate assumptions Amicus might make or by known or unknown risks and uncertainties. For example, with respect to statements regarding the goals, progress, timing and outcomes of ongoing discussions with regulatory authorities and the potential goals, progress, timing and results of clinical trials, actual results may differ materially from those set forth in this release due to the risks and uncertainties inherent in the business of Amicus, including, without limitation: the potential that data from the phase 3 trial design for Amigal is insufficient to support regulatory approval; the potential that results of clinical or pre-clinical studies indicate that the product candidates are unsafe or ineffective; and, our dependence on third parties in the conduct of our clinical studies. Further, the results of earlier clinical trials and studies may not be predictive of future results. Additionally, all forward looking statements are subject to other risks detailed in our Annual Report on Form 10-K for the year ended December 31, 2008, and our other public filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, and Amicus undertakes no obligation to revise or update this news release to reflect events or circumstances after the date hereof. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.

FOLD -G


'/>"/>
SOURCE Amicus Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
2. Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease
3. Amicus Therapeutics Announces Positive Results From Two Phase 1 Clinical Studies of AT2220 for Pompe Disease
4. Amicus Therapeutics to Present at the 26th Annual JPMorgan Healthcare Conference
5. Amicus Therapeutics Presents Data from Clinical Ex Vivo Response Study and Phase 1 Studies of AT2220
6. Amicus Therapeutics Begins Phase 2 Clinical Trial of AT2220 in Pompe Disease
7. Amicus Therapeutics Announces Successful Completion of End of Phase 2 Meeting With FDA for Amigal in Fabry Disease
8. Amicus Therapeutics Announces Second Quarter 2008 Financial Results
9. Amicus Therapeutics Announces Positive Progress of Three Lead Clinical Programs and General Outlook for 2009
10. Amicus Therapeutics Suspends Enrollment for Phase 2 Clinical Trial of AT2220 for Pompe Disease
11. Amicus Therapeutics Announces Issuance of New Plicera(TM) Composition of Matter Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... NEW YORK , May 22, 2015 /PRNewswire/ ... approval of Zarxio (filgrastim-sndz) -- the first biosimilar ... -- points toward growth in the ... Information. The mainstream CMO industry is geared to ... infrastructure to produce major biopharmaceutical products. The healthcare ...
(Date:5/22/2015)... -- The Mesothelioma Victims Center is incredibly passionate about ... best possible compensation, and they are also extremely focused ... caused by exposure to asbestos or their family ... options such as a recent possible medical breakthrough. For ... anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com ...
(Date:5/22/2015)... , May 22, 2015   InspireMD, Inc. (NYSE ... embolic protection systems ("EPS"), today announced that its CGuard TM ... by principle investigator Prof. Piotr Musialek , at the ... Paris, France . PARADIGM, an investigator-initiated ... cutaneous c A roti D revascularization I n ...
Breaking Medicine Technology:Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4
... Aug. 10, 2011 MSC Care Management, a national ... solutions to the workers, compensation industry, introduces MSC CareTrack, ... our customers manage patient care progress and product utilization. ... customers, targets vital patient feedback on the quality of ...
... Health Inc, Morrisville, NC has introduced IronUp, a Liquid ... dietary iron for infants and children who do not ... (Photo: http://photos.prnewswire.com/prnh/20110810/CL49882 ) ... supplement from a bioavailable source of iron that is ...
Cached Medicine Technology:MSC Monitors Patient Benchmarks on Behalf of Customers with MSC CareTrack 2YASOO Health Introduces IronUp™ 2
(Date:5/22/2015)... Carnegie Science Center and Allegheny ... to develop BodyTech, a dynamic, three-pronged health and science ... new exhibit at the Science Center called BodyWorks, the ... traveling science show, Anatomy Adventure, which will hit the ... to explore a wide range of topics surrounding health ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Power Systems is ... for the 2015 race season. Drobeck is in his second ... as a firefighter with the Missoula Fire Department in Missoula, ... a Pro in 2014. During his career, he has had ... Pro, Drobeck recorded top 10 finishes in all seven of ...
(Date:5/22/2015)... The dentist in West ... they are now offering complimentary consultations to patients ... At consultations, patients can discuss their candidacy for ... treatments can achieve and whether alternative options are ... appointment. If treatments are chosen, patients can start ...
(Date:5/22/2015)... 2015 A Phase 3 French ... Society of Clinical Oncology (ASCO)’s annual meeting at ... for those patients who received bevacizumab in addition ... Bevacizumab (Avastin® Genentech, Inc.) is an antibody that ... already routinely used to treat many other cancers, ...
(Date:5/22/2015)... In an effort to support the athletes ... to donate $5 dollars for every maintenance call, and ... softening system. Customers have their needs serviced, and donations ... and the Special Olympics receives money. Hence the name ... 4.4 million athletes, and boasts a myriad of events. ...
Breaking Medicine News(10 mins):Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2
... opening day, a series of articles in the Hastings ... and what it takes to stop cheating. New issues, including ... are really "female," are explored. "Making ... H. Murray, president of The Hastings Center and coeditor of ...
... damaged heart muscle, study found , THURSDAY, April 1 ... growth factor, or NGF, helped damaged heart muscles function ... effective treatments for people who have heart problems, researchers ... to investigate whether NGF can heal heart cells. Previous ...
... , ... Recent statistics from the American Society for Aesthetic Plastic Surgery ... Dr. Wally Zollman, a cosmetic plastic surgeon in Indianapolis , performs ... eliminate greater amounts of fat in specific body areas. In fact, Dr. ...
... A new study of brain activity in depressed and anxious ... are modified for better or for worse by ... & Behavioral Neuroscience , looked at depression and two types ... into panic; and anxious apprehension, better known as worry. ...
... cord injuries (SCI) are on the horizon, any eventual cure ... approach, drawing from expertise in several fields, according to a ... Journal of the American Academy of Orthopaedic Surgeons ... 12,000 men and women sustain and survive spinal cord injuries, ...
... March 31, 2010 The Association for Molecular ... association representing approximately 1,800 physicians, doctoral scientists, and ... on knowledge derived from molecular biology, genetics, and ... ruling in favor of the plaintiffs in the ...
Cached Medicine News:Health News:Baseball season opener: Athletes and ethicists look at fairness in sport 2Health News:Indianapolis Cosmetic Surgeon One of Few in Indiana Offering Patients Large Volume Liposuction, Brazilian Butt Lift 2Health News:Indianapolis Cosmetic Surgeon One of Few in Indiana Offering Patients Large Volume Liposuction, Brazilian Butt Lift 3Health News:Indianapolis Cosmetic Surgeon One of Few in Indiana Offering Patients Large Volume Liposuction, Brazilian Butt Lift 4Health News:Depressed? Fearful? It might help to worry, too 2Health News:Next decade offers promise for treatment of spinal cord injuries 2Health News:The Association for Molecular Pathology celebrates ruling in DNA patent case 2
Male Support Brief...
For Lipoplasty or surgery of abdomen, flanks and midriff...
Select Support Brief...
Female High Waist Briefs...
Medicine Products: